ArticleCureus2026
Maternal Immune Thrombocytopenia With Prior Splenectomy as a Cause of Severe Neonatal Thrombocytopenia: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe neonatal thrombocytopenia is a formidable complication of maternal immune thrombocytopenic purpura (ITP). We report the case of a male newborn, preterm at 32 weeks of gestation, presenting on day 4 of life with jaundice and severe cutaneous hemorrhagic syndrome. The maternal history was significant for severe ITP requiring splenectomy. The initial assessment showed a significant drop in platelets, with a count of 6,000/mm³, even though the bone marrow aspirate appeared normal. Treatment included corticosteroids, platelet transfusions, polyvalent immunoglobulins, and phototherapy. This approach led to a gradual improvement, and the platelet count returned to normal within three months. This case highlights the association between the severity of maternal ITP and the risk of severe neonatal thrombocytopenia. It also emphasizes the importance of a thorough, team-based treatment plan that combines treatments to relieve symptoms with immunomodulatory therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.